Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (125 ms)
| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1160.68/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68 |
| Version | 20241016 |
| Status | active |
| Date | 2024-10-16T01:07:54-04:00 |
| Name | PotassiumSparingDiureticForHypertension |
| Title | Potassium Sparing Diuretic for Hypertension |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Potassium Sparing Diuretic pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Potassium Sparing Diuretic pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Potassium Sparing Diuretic pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.) |
Resources that use this resource
Resources that this resource uses
Source
{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113762.1.4.1160.68",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2024-11-26T11:15:10.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "HSAG Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-10-16"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2024-10-16"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.68",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113762.1.4.1160.68"
}
],
"version" : "20241016",
"name" : "PotassiumSparingDiureticForHypertension",
"title" : "Potassium Sparing Diuretic for Hypertension",
"status" : "active",
"date" : "2024-10-16T01:07:54-04:00",
"publisher" : "American Medical Association Steward",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts that represent medications in the Potassium Sparing Diuretic pharmacologic class that are specifically indicated for the treatment of essential hypertension.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent generic, human use, and prescribable medications of the Potassium Sparing Diuretic pharmacologic class with a Semantic Clinical Drug (SCD) or Generic Pack (GPCK) term type that have a route of administration of: oral/pill, oral suspension, injectables, and transdermal.),(Exclusion Criteria: Excludes concepts that represent medications in the Potassium Sparing Diuretic pharmacologic class with a route of administration of: ophthalmic, topical, foams, creams, and shampoo.)",
"compose" : {
"include" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept" : [
{
"code" : "198312",
"display" : "triamterene 100 MG Oral Capsule"
},
{
"code" : "198313",
"display" : "triamterene 50 MG Oral Capsule"
},
{
"code" : "198314",
"display" : "hydrochlorothiazide 25 MG / triamterene 50 MG Oral Capsule"
},
{
"code" : "198316",
"display" : "hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule"
},
{
"code" : "310812",
"display" : "hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet"
},
{
"code" : "310818",
"display" : "hydrochlorothiazide 50 MG / triamterene 75 MG Oral Tablet"
},
{
"code" : "977880",
"display" : "amiloride hydrochloride 5 MG Oral Tablet"
},
{
"code" : "977883",
"display" : "amiloride hydrochloride 5 MG / hydrochlorothiazide 50 MG Oral Tablet"
}
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:266ab7cb-332a-44c5-bd0e-aa6d04bc00ef",
"timestamp" : "2024-12-10T07:17:45-05:00",
"total" : 8,
"contains" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198312",
"display" : "triamterene 100 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198313",
"display" : "triamterene 50 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198314",
"display" : "hydrochlorothiazide 25 MG / triamterene 50 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "198316",
"display" : "hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "310812",
"display" : "hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "310818",
"display" : "hydrochlorothiazide 50 MG / triamterene 75 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "977880",
"display" : "amiloride hydrochloride 5 MG Oral Tablet"
},
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"version" : "11042024",
"code" : "977883",
"display" : "amiloride hydrochloride 5 MG / hydrochlorothiazide 50 MG Oral Tablet"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.
FHIR